[144] Abercrombie & Fitch Co. SEC Filing
Form 144 filed for Abercrombie & Fitch Co. (ANF) reports a proposed sale of 5,072 Class A shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $487,836.41 and 47,643,315 Class A shares outstanding. The notice shows the shares were acquired via restricted stock vesting: 4,292 shares vested on 06/08/2024 and 780 shares vested on 06/11/2025, with compensation listed as the payment nature. The approximate sale date is 08/29/2025. Certain issuer and filer identification fields (including issuer name details and filer CIK/CCC) are not populated in the provided content.
- Disclosure of acquisition method: The filing specifies the shares were acquired via restricted stock vesting, clarifying the source of the securities
- Broker and market specified: Sale through Fidelity Brokerage Services on the NYSE with an approximate sale date, supporting transactional transparency
- Compensation payment noted: The form lists compensation as the nature of payment for the vested shares, consistent with executive equity awards
- Missing issuer/filer identifiers in provided excerpt: Key fields such as issuer name details and filer CIK/CCC are not populated in the supplied content
- Limited context on intent or trading plan: The excerpt does not show whether a 10b5-1 trading plan exists or plan adoption date, reducing clarity on preplanned selling
Insights
TL;DR: Small, routine insider sale of vested restricted shares through a major broker; disclosure meets Rule 144 procedural requirements.
The filing documents a planned sale of 5,072 Class A shares on the NYSE via Fidelity. The shares were acquired through restricted stock vesting and are identified as compensation, which is a common source for Rule 144 notices. The aggregate market value is stated as $487,836.41. Given the absolute share count and use of a standard brokerage channel, this appears procedural rather than signaling a major corporate event. The filing, however, omits several identifying fields such as issuer details and filer CIK/CCC in the provided extract, which reduces clarity for third‑party reviewers.
TL;DR: Disclosure shows compliance with insider-sale notification norms but lacks some identifying information in the submitted excerpt.
The Form 144 indicates the seller relied on restricted stock vesting as the acquisition source, and the seller affirms no undisclosed material adverse information. Use of Fidelity Brokerage Services and a specified sale date are appropriate procedural details. From a governance perspective, the filing documents compensation-related insider holdings being sold, which is routine. The absence of filled issuer and filer identification fields in the supplied content should be checked against the full filing to ensure completeness and traceability for investors and regulators.